| Part Of Open Phones
Washington Journal
Report Video IssueWashington Journal
Open Phones
2004-12-18T06:59:58-05:00https://ximage.c-spanvideo.org/eyJidWNrZXQiOiJwaWN0dXJlcy5jLXNwYW52aWRlby5vcmciLCJrZXkiOiJGaWxlc1wvMGQ2XC8yMDA0MTIxODA3MDUzNzAwMV9oZC5qcGciLCJlZGl0cyI6eyJyZXNpemUiOnsiZml0IjoiY292ZXIiLCJoZWlnaHQiOjUwNn19fQ==Telephone lines were open for audience comments on the Food and Drug Administration’s approval process. The question pertains to the regulatory agency’s halting of the trial for the painkiller Celebrex, due to a heart risk.
Telephone lines were open for audience comments on the Food and Drug Administration’s approval process. The question pertains to the regulatory agency’s halting of the trial for the painkiller Celebrex, due to a heart risk.
Telephone lines were open for audience comments on the Food and Drug Administration’s approval process. The question pertains to the regulatory agency’s halting of the trial for the painkiller Celebrex, due to a heart risk.
People in this video
Hosting Organization
Series
More Videos From
Open Phones
- Investigation into Fannie Mae
- State Levels of Emergency Preparedness
- European Union Membership for Turkey
Related Video
-
Open Phones
Telephone lines were open for viewer comments on the question, “Should painkiller Celebrex be pulled from the market?”
-
Open Phones
Telephone lines were open for viewer comments on the question, “Is the U.S. overreacting to painkiller news?”
-
Open Phones
Telephone lines were open for viewer comments on news of the day. Callers discussed whether the ruling to delay over the…
-
Open Phones
Viewers of the morning program were asked to call in and comment on the question “Can You Trust Canadian Drug Imports?” …